Hui Tian

Hui Tian

Private Equity Investor en The Column Group LLC .

Health Technology
Consumer Services
Commercial Services

Perfil

Dr. Hui Tian joined The Column Group in 2022 as a Venture Partner.
Previously he was a founding member of NGM Biopharmaceuticals and most recently served as Senior Vice President of Research.
In this role, he was responsible for discovery research across multiple therapeutic areas including metabolic diseases, retinal diseases and cancer.
In a span of 14 years, he led the discovery and advancement of more than a dozen clinical candidates.
Prior to NGM, he was a Scientific Director at Amgen and Tularik leading discovery research in the areas of metabolic disorders and orphan G protein-coupled receptors.
Dr. Tian received a Ph.D.
in Molecular and Cellular Biology at the University of Texas Southwestern Medical Center and did his post-doctoral training at Harvard University.

Cargos activos de Hui Tian

EmpresasCargoInicio
Private Equity Investor 01/03/2022
Todos los cargos activos de Hui Tian

Antiguos cargos conocidos de Hui Tian.

EmpresasCargoFin
NGM BIOPHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 31/05/2022
AMGEN INC. Corporate Officer/Principal 31/12/2008
Corporate Officer/Principal 31/12/2004
Ver el detalle de la experiencia de Hui Tian.

Formación de Hui Tian.

Harvard University Doctorate Degree
The University of Texas Southwestern Medical Center Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Hui Tian.

Relaciones

100 +

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
AMGEN INC.

Health Technology

NGM BIOPHARMACEUTICALS, INC.

Health Technology

Empresas privadas2

Commercial Services

Finance

Ver las conexiones de la empresa